24. Juni 2020 – In a recent decision, the Federal Administrative Court held that a therapeutic cross comparison (TQV) is unlawful if the assumed dosages are not based on the expert information. The complaint was approved and the case was referred back to the lower instance for a new decision. For the full decision, see here.